OUTLOOK THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.245 USD | -0.54% |
|
-8.30% | +5.20% |
Chart calendar Outlook Therapeutics, Inc.
053bb266045b7.LNfqq8VbOz0Ec04rqmjOSkfC8Vfm9h7MgYDT_f421w0.Rbqi7qEiUERGRiAcwy-6AD3xtmCTvkb17fSayJJ94GxE4b3gjT0WBEkJfg~b528f4f773e8a566ea692506496c21f7
Upcoming events on Outlook Therapeutics, Inc.
Past events on Outlook Therapeutics, Inc.
| 2024-03-07 10:00 am | Annual General Meeting |
| 2024-02-14 08:05 am | Q1 2024 Earnings Release |
| 2023-12-22 08:05 am | Q4 2023 Earnings Release |
| 2023-11-07 01:50 pm | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-09-26 01:35 pm | Cantor Global Healthcare Conference |
| 2023-09-13 09:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-30 08:30 am | Business Update Call |
| 2023-08-14 08:05 am | Q3 2023 Earnings Release |
| 2023-08-07 01:00 pm | BTIG Virtual Biotechnology Conference |
| 2023-05-15 08:05 am | Q2 2023 Earnings Release |
| 2023-05-02 02:00 pm | H.C. Wainwright BioConnect Investor Conference |
| 2023-03-29 10:00 am | Annual General Meeting |
| 2023-02-14 04:20 pm | SVB Securities Global Biopharma Conference |
| 2023-02-14 08:05 am | Q1 2023 Earnings Release |
| 2023-01-17 11:00 am | Virtual Investor Conference |
| 2022-12-29 09:05 am | FY 2022 Earnings Release |
| 2022-12-08 02:45 pm | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference |
| 2022-11-29 12:30 pm | BTIG Ophthalmology Day - Fireside Chat |
| 2022-09-29 02:46 pm | Eyecelerator AAO Conference |
| 2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,15 2,91 180.2% | 0,00 0,13 - | 0,00 0,20 - | 0,00 0,00 - | 0,00 0,18 - | 0,20 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -36,3 -31,2 -16.45% | -36,8 -37,3 1.17% | -51,7 -46,3 -11.61% | -63,1 -64,8 2.67% | -53,1 -56,2 5.44% | -67,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,9 -34,3 -10.65% | -38,5 -42,5 9.42% | -53,2 -47,9 -10.99% | -66,0 -67,4 2.06% | -59,0 -62,5 5.63% | -71,8 |
|
Net income Million USD | Released Forecast Spread | -36,0 -34,4 -4.7% | -48,9 -51,5 5.02% | -53,2 -48,0 -10.87% | -66,1 -66,8 1.11% | -59,0 -61,7 4.48% | -72,0 |
|
EPS USD | Released Forecast Spread | -39,6 -39,7 0.34% | -13,4 -16,8 20% | -7,00 -6,30 -11.11% | -6,20 -6,24 0.64% | -4,80 -4,86 1.18% | -3,34 |
| Announcement Date | 19/12/19 | 23/12/20 | 22/12/21 | 29/12/22 | 22/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,04 - | 0,00 0,18 - | 0,00 0,00 - | 0,00 | 0,00 | 0,20 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -13,1 -13,1 -0.63% | -18,9 -12,7 -49.18% | -17,0 -16,6 -2.32% | -14,0 -15,4 9.03% | -15,7 -17,3 9.44% | -6,84 -14,2 51.85% | -18,1 -11,9 -53.04% | -12,5 -15,5 19.61% | -10,3 -12,4 16.75% | -16,9 | -21,0 | -19,2 | -14,0 | -14,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,5 -13,7 -5.47% | -19,7 -13,5 -46.01% | -17,5 -17,3 -1.16% | -14,3 -17,0 15.75% | -18,7 -12,9 -44.69% | -6,65 -16,4 59.46% | -20,7 -14,1 -46.25% | -13,0 -16,6 21.84% | -11,2 -15,0 25.71% | -18,4 | -22,1 | -20,1 | -16,5 | -16,5 |
|
Net income Million USD | Released Forecast Spread | -14,5 -13,7 -5.47% | -19,7 -13,5 -46.02% | -17,5 -17,3 -1.16% | -14,3 -15,9 9.75% | -18,7 -12,9 -44.69% | -6,65 -15,4 56.8% | -20,7 -13,7 -50.61% | -13,0 -15,9 18.04% | -11,2 -15,0 25.71% | -18,1 | -22,1 | -20,5 | -16,5 | -16,5 |
|
EPS USD | Released Forecast Spread | -1,60 -1,20 -33.33% | -1,80 -1,27 -42.1% | -1,60 -1,47 -9.09% | -1,20 -1,35 11.11% | -1,60 -0,20 -700% | -0,60 -1,15 47.83% | -1,60 -1,03 -54.84% | -1,00 -1,14 12.5% | -0,80 -1,00 20% | -0,91 | -0,86 | -0,89 | -0,80 | -0,80 |
| Announcement Date | 14/02/22 | 13/05/22 | 10/08/22 | 29/12/22 | 14/02/23 | 15/05/23 | 14/08/23 | 22/12/23 | 14/02/24 | - | - | - | - | - |
More events
Past sector events for Outlook Therapeutics, Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OTLK Stock
- Calendar Outlook Therapeutics, Inc.
